FDA Device Intelligence
Home › PEAR THERAPEUTICS, INC. › reSET-O® Introductory Access Limited Version (Mobile App, Android)

reSET-O® Introductory Access Limited Version (Mobile App, Android)

PEAR THERAPEUTICS, INC. · Model 1 · UDI-DI 10851580008187

PWE Prescription
1
510(k) clearances
2
Adverse events (1 deaths)
2
Recalls
1
Facilities

Description

reSET-O® Mobile Application running on Android. reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Introductory Access Limited Version provides limited access to the reSET-O product.

Recalls

DateFirmReason
2021-06-07Pear Therapeutics, Inc.Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positi
2021-06-07Pear Therapeutics, Inc.Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positi

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.